iShares US Pharmaceuticals ETF (IHE)
iShares US Pharmaceuticals ETF (IHE) — healthcare and biotech ETF. Analyze it on ETF Copilot.
Tracks U.S. pharmaceutical manufacturers through a cap-weighted index.
Functions as a high-valuation pharmaceutical allocation for a portfolio already holding broad health sector exposure.
76% of IHE is its ten largest holdings.
More concentrated than 98% of Healthcare & Biotech ETFs.
What's inside IHE: Size (large 61%, mid 25%, small 14%); Geography (international 5%, us 96%).
As of July 29, 2026, ETF Copilot scores iShares US Pharmaceuticals ETF (IHE) 4.3 out of 10 overall.
Updated July 29, 2026
ETF Copilot scores (0–10 scale, higher is better):
- Overall: 4.3 / 10
- Growth: 0.5 / 10
- Valuation: 1.6 / 10
- Risk: 6.8 / 10
- Profitability: 7.3 / 10
- Return: 6.2 / 10
Register free to unlock IHE's price, fees, yield, and holdings on ETF Copilot.
Register free →